There is evidence that titrating GLP-1 dosage and switching between GLP-1 medications can occur in clinical practice due to factors such as lack of desired impact, patient preference, insurance coverage and side effects
The MPATH-Dx Reporting Schema for Melanocytic Proliferations and Melanoma
The review found that serious anesthesia risks linked to these drugs are uncommon for most patients and can usually be managed through individualized planning rather than stopping the medication
"In addiction medicine, a lot of treatments target just one thing, for example, a nicotine patch helps with smoking, but not alcohol, but there is no medication that works across addictive substances, let alone all of them," said senior author Ziyad Al-Aly, MD, a WashU Medicine clinical epidemiologist and Chief of the Research and Development Service at the VA Saint Louis Health Care System